60 related articles for article (PubMed ID: 8502472)
1. Absence of a paused transcription complex from the c-myc P2 promoter of the translocation chromosome in Burkitt's lymphoma cells: implication for the c-myc P1/P2 promoter shift.
Strobl LJ; Kohlhuber F; Mautner J; Polack A; Eick D
Oncogene; 1993 Jun; 8(6):1437-47. PubMed ID: 8502472
[TBL] [Abstract][Full Text] [Related]
2. Activation of c-myc promoter P1 by immunoglobulin kappa gene enhancers in Burkitt lymphoma: functional characterization of the intron enhancer motifs kappaB, E box 1 and E box 2, and of the 3' enhancer motif PU.
Wittekindt NE; Hörtnagel K; Geltinger C; Polack A
Nucleic Acids Res; 2000 Feb; 28(3):800-8. PubMed ID: 10637333
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of potential role of R-loop and G-quadruplex DNA in the fragility of c-MYC during chromosomal translocation associated with Burkitt's lymphoma.
Kumari N; Das K; Sharma S; Dahal S; Desai SS; Roy U; Sharma A; Manjunath M; Gopalakrishnan V; Retheesh ST; Javadekar SM; Choudhary B; Raghavan SC
J Biol Chem; 2023 Dec; 299(12):105431. PubMed ID: 37926284
[TBL] [Abstract][Full Text] [Related]
4. Immunoglobulin heavy variable (IgHV) gene mutation and micro-RNA expression in Burkitt's lymphoma at Moi Teaching and Referral Hospital in Western Kenya.
Ndede I; Mining SK; Patel K; Wanjala FM; Tenge C
Afr Health Sci; 2019 Dec; 19(4):3242-3248. PubMed ID: 32127902
[TBL] [Abstract][Full Text] [Related]
5. Myc dynamically and preferentially relocates to a transcription factory occupied by Igh.
Osborne CS; Chakalova L; Mitchell JA; Horton A; Wood AL; Bolland DJ; Corcoran AE; Fraser P
PLoS Biol; 2007 Aug; 5(8):e192. PubMed ID: 17622196
[TBL] [Abstract][Full Text] [Related]
6. Enhancers predominantly regulate gene expression during differentiation via transcription initiation.
Larke MSC; Schwessinger R; Nojima T; Telenius J; Beagrie RA; Downes DJ; Oudelaar AM; Truch J; Graham B; Bender MA; Proudfoot NJ; Higgs DR; Hughes JR
Mol Cell; 2021 Mar; 81(5):983-997.e7. PubMed ID: 33539786
[TBL] [Abstract][Full Text] [Related]
7. RNA polymerase II dynamics shape enhancer-promoter interactions.
Barshad G; Lewis JJ; Chivu AG; Abuhashem A; Krietenstein N; Rice EJ; Ma Y; Wang Z; Rando OJ; Hadjantonakis AK; Danko CG
Nat Genet; 2023 Aug; 55(8):1370-1380. PubMed ID: 37430091
[TBL] [Abstract][Full Text] [Related]
8. G-quadruplex DNA structure is a positive regulator of
Esain-Garcia I; Kirchner A; Melidis L; Tavares RCA; Dhir S; Simeone A; Yu Z; Madden SK; Hermann R; Tannahill D; Balasubramanian S
Proc Natl Acad Sci U S A; 2024 Feb; 121(7):e2320240121. PubMed ID: 38315865
[TBL] [Abstract][Full Text] [Related]
9. Antitumor efficacy of a sequence-specific DNA-targeted γPNA-based c-Myc inhibitor.
Malik S; Pradeep SP; Kumar V; Xiao Y; Deng Y; Fan R; Vasquez JC; Singh V; Bahal R
Cell Rep Med; 2024 Jan; 5(1):101354. PubMed ID: 38183981
[TBL] [Abstract][Full Text] [Related]
10. Epstein-Barr virus and Burkitt lymphoma.
Brady G; MacArthur GJ; Farrell PJ
J Clin Pathol; 2007 Dec; 60(12):1397-402. PubMed ID: 18042696
[TBL] [Abstract][Full Text] [Related]
11. Transition from initiation to promoter proximal pausing requires the CTD of RNA polymerase II.
Lux C; Albiez H; Chapman RD; Heidinger M; Meininghaus M; Brack-Werner R; Lang A; Ziegler M; Cremer T; Eick D
Nucleic Acids Res; 2005; 33(16):5139-44. PubMed ID: 16157863
[TBL] [Abstract][Full Text] [Related]
12. Burkitt lymphoma in the mouse.
Kovalchuk AL; Qi CF; Torrey TA; Taddesse-Heath L; Feigenbaum L; Park SS; Gerbitz A; Klobeck G; Hoertnagel K; Polack A; Bornkamm GW; Janz S; Morse HC
J Exp Med; 2000 Oct; 192(8):1183-90. PubMed ID: 11034608
[TBL] [Abstract][Full Text] [Related]
13. The immunoglobulin heavy chain locus control region increases histone acetylation along linked c-myc genes.
Madisen L; Krumm A; Hebbes TR; Groudine M
Mol Cell Biol; 1998 Nov; 18(11):6281-92. PubMed ID: 9774645
[TBL] [Abstract][Full Text] [Related]
14. Regulation of expression of nuclear and mitochondrial forms of human uracil-DNA glycosylase.
Haug T; Skorpen F; Aas PA; Malm V; Skjelbred C; Krokan HE
Nucleic Acids Res; 1998 Mar; 26(6):1449-57. PubMed ID: 9490791
[TBL] [Abstract][Full Text] [Related]
15. Nucleosomal structures of c-myc promoters with transcriptionally engaged RNA polymerase II.
Albert T; Mautner J; Funk JO; Hörtnagel K; Pullner A; Eick D
Mol Cell Biol; 1997 Aug; 17(8):4363-71. PubMed ID: 9234694
[TBL] [Abstract][Full Text] [Related]
16. Negative protein 1, which is required for function of the chicken lysozyme gene silencer in conjunction with hormone receptors, is identical to the multivalent zinc finger repressor CTCF.
Burcin M; Arnold R; Lutz M; Kaiser B; Runge D; Lottspeich F; Filippova GN; Lobanenkov VV; Renkawitz R
Mol Cell Biol; 1997 Mar; 17(3):1281-8. PubMed ID: 9032255
[TBL] [Abstract][Full Text] [Related]
17. In vivo generation of 3' and 5' truncated species in the process of c-myc mRNA decay.
Ioannidis P; Havredaki M; Courtis N; Trangas T
Nucleic Acids Res; 1996 Dec; 24(24):4969-77. PubMed ID: 9016668
[TBL] [Abstract][Full Text] [Related]
18. TATA box and Sp1 sites mediate the activation of c-myc promoter P1 by immunoglobulin kappa enhancers.
Geltinger C; Hörtnagel K; Polack A
Gene Expr; 1996; 6(2):113-27. PubMed ID: 8979089
[TBL] [Abstract][Full Text] [Related]
19. An exceptionally conserved transcriptional repressor, CTCF, employs different combinations of zinc fingers to bind diverged promoter sequences of avian and mammalian c-myc oncogenes.
Filippova GN; Fagerlie S; Klenova EM; Myers C; Dehner Y; Goodwin G; Neiman PE; Collins SJ; Lobanenkov VV
Mol Cell Biol; 1996 Jun; 16(6):2802-13. PubMed ID: 8649389
[TBL] [Abstract][Full Text] [Related]
20. Multiple single-stranded cis elements are associated with activated chromatin of the human c-myc gene in vivo.
Michelotti GA; Michelotti EF; Pullner A; Duncan RC; Eick D; Levens D
Mol Cell Biol; 1996 Jun; 16(6):2656-69. PubMed ID: 8649373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
